63323-574Level 3
Icatibant (Icatibant)
**Product type:** Human Prescription Drug
**Active ingredient:** ICATIBANT ACETATE
**Strength:** 10 mg/mL
**Dosage form:** Injection, Solution
**Route:** Subcutaneous
**Labeler:** Fresenius Kabi USA, LLC
**Marketing category:** ANDA (ANDA208317)
**Pharmacologic class:** Bradykinin B2 Receptor Antagonist [EPC], Bradykinin B2 Receptor Antagonists [MoA]
GET
/api/v1/systems/ndc_fda/nodes/63323-574Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.